Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 10, 2000, Pages 866-871

  Minghetti, Luisa ^a   Greco, Anita ^a   Cardone, Franco ^a   Puopolo, Maria ^a   Ladogana, Anna ^a   Almonti, Susanna ^a   Cunningham, Colm ^b   Perry, V Hugh ^b   Pocchiari, Maurizio ^a   Levi, Giulio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Brain inflammation; Creutzfeldt Jakob disease; Lipid peroxidation; Neurodegeneration; Prion diseases; Prostanoids; Scrapie

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID DERIVATIVE; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE DURATION; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRION DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; SCRAPIE AGENT; SURVIVAL RATE;

EID: 0033782842     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.10.866     Document Type: Article

References (41)

1. Prions
2. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995
3. Evidence for an early inflammatory response in the central nervous system of mice with scrapie
4. Microglia and the development of spongiform change in Creutzfeldt-Jakob disease
5. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
6. The contribution of inflammation to acute and chronic neurodegeneration
7. Microglia: A sensor for pathological events in the CNS
8. Reorientation of prostanoid production accompanies 'activation' of adult microglial cells in culture
9. Prostaglandins as putative neurotoxins in Alzheimer's disease
10. 2 levels in patients with probable AD
11. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide
12. 1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord
13. Oxidative stress in neurological disease
14. Free radicals antioxidants and human disease: Where are we now?
15. Measurement of lipid peroxidation
16. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis
17. 2-isoprostanes are elevated in Huntington's disease
18. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
19. Role of microglia in neuronal cell death in prion disease
20. Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease
21. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeld-Jakob disease
22. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
23. High incidence of Creutzfeldt-Jakob disease in rural Calabria, Italy
24. A new point mutation of the prion protein gene in Creutzfeldt Jakob disease
25. Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease
26. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia
27. Cerebrospinal fluid prostaglandins after systemic dipyrone intake
28. Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man
29. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy
30. Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease
31. Cytokine, prostaglandin and lipocortin-1 are present in the brain of scrapie-infected mice
32. Cyclooxygenases and the central nervous system
33. Differential cellular distribution and dynamics of Hsp70, cyclooxygenase-2 and c-fos in the rat brain after transient focal ischemia or kainic acid
34. Porphyrin and phthalocyanine antiscrapie compounds
35. Congo red prolongs the incubation period in scrapie-infected hamsters
36. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation
37. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides
38. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters
39. Elimination of prions by branched polyamines and implications for therapeutics
40. COX-2 inhibitors